<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Tall on Tenu Tech Brief</title>
    <link>https://cluster-site.onrender.com/tags/tall/</link>
    <description>Recent content in Tall on Tenu Tech Brief</description>
    <generator>Hugo -- 0.146.0</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 24 Feb 2026 06:03:17 +0000</lastBuildDate>
    <atom:link href="https://cluster-site.onrender.com/tags/tall/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA Filing</title>
      <link>https://cluster-site.onrender.com/posts/bridgebio-stands-tall-as-phase-3-data-put-dwarfism-drug-on-track-for-fda-filing/</link>
      <pubDate>Thu, 12 Feb 2026 19:26:04 +0000</pubDate>
      <guid>https://cluster-site.onrender.com/posts/bridgebio-stands-tall-as-phase-3-data-put-dwarfism-drug-on-track-for-fda-filing/</guid>
      <description>• A BridgeBio Pharma drug developed for dwarfism increased children&amp;rsquo;s growth rates in a pivotal clinical trial,meeting the study&amp;rsquo;s main goaland boosting the daily pill&amp;rsquo;s chances to</description>
    </item>
  </channel>
</rss>
